Dunkin Donuts   Report issue

For profit Phase 1
Founded: Canton MA United States (1950)
Status: No NME R&D (1950)

Organization Overview

First Clinical Trial
2019
NCT04024761
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Dunkin Donuts

Active Ingredients

Drugs in Phase 1 Trials (3)

ciml nk (1 trial)

cyclophosphamide (cytoxan) (1 trial)

fludarabine (fludara) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 1)

Recurrence (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 3